Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Active, not recruiting · NCT04564703 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-07-16 | NCT04564703 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| EMN Research Italy Impresa Sociale Srl | 1 |
| Healt Data Specialists - HeaDS (CRO) | 1 |
| Stichting European Myeloma Network | 4 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.